Terms: = Ovarian cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
15 results:
1. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Smith M; Dai A; Ghilardi G; Amelsberg KV; Devlin SM; Pajarillo R; Slingerland JB; Beghi S; Herrera PS; Giardina P; Clurman A; Dwomoh E; Armijo G; Gomes ALC; Littmann ER; Schluter J; Fontana E; Taur Y; Park JH; Palomba ML; Halton E; Ruiz J; Jain T; Pennisi M; Afuye AO; Perales MA; Freyer CW; Garfall A; Gier S; Nasta S; Landsburg D; Gerson J; Svoboda J; Cross J; Chong EA; Giralt S; Gill SI; Riviere I; Porter DL; Schuster SJ; Sadelain M; Frey N; Brentjens RJ; June CH; Pamer EG; Peled JU; Facciabene A; van den Brink MRM; Ruella M
Nat Med; 2022 Apr; 28(4):713-723. PubMed ID: 35288695
[TBL] [Abstract] [Full Text] [Related]
2. Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating pim1.
Li Q; Jiang C; Wang Y; Wei M; Zheng H; Xu Y; Xu X; Jia F; Liu K; Sun G; Zang J; Mo P
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1477-1489. PubMed ID: 31292669
[TBL] [Abstract] [Full Text] [Related]
3. pim Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of ovarian cancer.
Aziz AUR; Farid S; Qin K; Wang H; Liu B
Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29401696
[TBL] [Abstract] [Full Text] [Related]
4. Guanylate-Binding Protein-1 protects ovarian cancer cell lines but not breast cancer cell lines from killing by paclitaxel.
Tipton AR; Nyabuto GO; Trendel JA; Mazur TM; Wilson JP; Wadi S; Justinger JS; Moore GL; Nguyen PT; Vestal DJ
Biochem Biophys Res Commun; 2016 Sep; 478(4):1617-23. PubMed ID: 27590579
[TBL] [Abstract] [Full Text] [Related]
5. XCR1 promotes cell growth and migration and is correlated with bone metastasis in non-small cell lung cancer.
Wang T; Han S; Wu Z; Han Z; Yan W; Liu T; Wei H; Song D; Zhou W; Yang X; Xiao J
Biochem Biophys Res Commun; 2015 Aug; 464(2):635-41. PubMed ID: 26166822
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant expression of pim-3 promotes proliferation and migration of ovarian cancer cells.
Zhuang H; Zhao MY; Hei KW; Yang BC; Sun L; Du X; Li YM
Asian Pac J Cancer Prev; 2015; 16(8):3325-31. PubMed ID: 25921139
[TBL] [Abstract] [Full Text] [Related]
7. Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation.
Lin F; Luo X; Tsun A; Li Z; Li D; Li B
Int Immunopharmacol; 2015 Oct; 28(2):859-65. PubMed ID: 25870037
[TBL] [Abstract] [Full Text] [Related]
8. Identification of the first inhibitor of the GBP1:pim1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.
Andreoli M; Persico M; Kumar A; Orteca N; Kumar V; Pepe A; Mahalingam S; Alegria AE; Petrella L; Sevciunaite L; Camperchioli A; Mariani M; Di Dato A; Novellino E; Scambia G; Malhotra SV; Ferlini C; Fattorusso C
J Med Chem; 2014 Oct; 57(19):7916-32. PubMed ID: 25211704
[TBL] [Abstract] [Full Text] [Related]
9. pim2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.
Musiani D; Hammond DE; Cirillo L; Erriquez J; Olivero M; Clague MJ; Di Renzo MF
J Proteome Res; 2014 Nov; 13(11):4970-82. PubMed ID: 25099161
[TBL] [Abstract] [Full Text] [Related]
10. SGI-1776, an imidazo pyridazine compound, inhibits the proliferation of ovarian cancer cells by inactivating pim-1.
Xie J; Bai J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 39(7):649-57. PubMed ID: 25080901
[TBL] [Abstract] [Full Text] [Related]
11. Arthrinins A-D: novel diterpenoids and further constituents from the sponge derived fungus Arthrinium sp.
Ebada SS; Schulz B; Wray V; Totzke F; Kubbutat MH; Müller WE; Hamacher A; Kassack MU; Lin W; Proksch P
Bioorg Med Chem; 2011 Aug; 19(15):4644-51. PubMed ID: 21741249
[TBL] [Abstract] [Full Text] [Related]
12. Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer.
De Donato M; Mariani M; Petrella L; Martinelli E; Zannoni GF; Vellone V; Ferrandina G; Shahabi S; Scambia G; Ferlini C
J Cell Physiol; 2012 Mar; 227(3):1034-41. PubMed ID: 21520077
[TBL] [Abstract] [Full Text] [Related]
13. High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model.
Tsuda H; Fukamachi K; Ohshima Y; Ueda S; Matsuoka Y; Hamaguchi T; Ohnishi T; Takasuka N; Naito A
Cancer Sci; 2005 Jun; 96(6):309-16. PubMed ID: 15958052
[TBL] [Abstract] [Full Text] [Related]
14. Gonadotropin-induced gene regulation in human granulosa cells obtained from IVF patients: modulation of genes coding for growth factors and their receptors and genes involved in cancer and other diseases.
Rimon E; Sasson R; Dantes A; Land-Bracha A; Amsterdam A
Int J Oncol; 2004 May; 24(5):1325-38. PubMed ID: 15067357
[TBL] [Abstract] [Full Text] [Related]
15. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract] [Full Text] [Related]
